In addition, W-Tau protein levels are diminished in Alzheimer’s disease patients with respect to control, non-demented subjects, thus suggesting a role in the development and progression of the disease [37]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.